Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
The Journal of Infectious Diseases|August 7, 1999
The role of B/T costimulatory signals in the immunopotentiating activity of neisserial porinF G Mackinnon, Y Ho, M S Blake, et al.
Vaccine|November 5, 1999
Safety and immunogenicity of a new Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine in healthy adultsP Richmond, D Goldblatt, P C Fusco, et al.
The Journal of Biological Chemistry|October 25, 1990
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B StreptococcusL C Paoletti, D L Kasper, F Michon, et al.
The Journal of Clinical Investigation|January 1, 1992
Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugatesL C Paoletti, D L Kasper, F Michon, et al.
Vaccine|January 1, 1993
Further studies on the adjuvanticity of stearyl tyrosine and ester analoguesC L Penney, D Ethier, G Dionne, et al.
The Journal of Clinical Investigation|November 1, 1990
Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B StreptococcusM R Wessels, L C Paoletti, D L Kasper, et al.
Infection and Immunity|November 1, 1993
Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccineM R Wessels, L C Paoletti, A K Rodewald, et al.
Vaccine|October 31, 1998
Preclinical studies on a recombinant group B meningococcal porin as a carrier for a novel Haemophilus influenzae type b conjugate vaccineP C Fusco, F Michon, M Laude-Sharp, et al.
The Journal of Biological Chemistry|April 15, 1991
Structural determination and immunochemical characterization of the type V group B Streptococcus capsular polysaccharideM R Wessels, J L DiFabio, V J Benedì, et al.
Journal of Dental Research|July 18, 2020
<i>Sox2</i> Controls Periderm and Rugae Development to Inhibit Oral AdhesionsY Y Sweat, M Sweat, W Yu, et al.
Pageof 6